Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-12-30
1995-11-28
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 285, 536 2853, 514 49, A61K 3170, C07H 19067
Patent
active
054708389
ABSTRACT:
Methods of delivering exogenous uridine or cytidine to the tissue of an animal comprising the administration of acyl derivatives of uridine or cytidine, respectively, are disclosed. Also disclosed are methods for treating cardiac insufficiency, myocardial infarction, cirrhosis of the liver, each comprising administration of acyl derivatives of uridine or cytidine.
REFERENCES:
patent: 3585188 (1971-06-01), Ryuji
patent: 3847898 (1974-11-01), Kelly
patent: 3868451 (1975-02-01), Stein et al.
patent: 3894000 (1975-07-01), Wechter et al.
patent: 3975367 (1975-08-01), Gish et al.
patent: 3991045 (1976-11-01), Ichida et al.
patent: 4022963 (1977-05-01), Deutsch
patent: 4868162 (1989-09-01), Kawaguchi et al.
Ensminger et al. Biochem. Pharm. 28: 1541-1545, 1979.
Chemical Abstracts 105:112608x, Lortet et al. Basic Res. Cardiol. 81(3): 303-310 (1986).
Chemical Abstracts 101:149186b, Aussedat et al. Mol. Physiol. 6(3-4): 247-55 (1984).
Martin et al (1987) J. of Pharm. Sc., vol. 76, No. 2, pp. 180-184.
Hackh's Chemical Dictionary 3rd ed. Julius Grant, ed pp. 44, 45, 332-333, 1944.
Rajabales, the Chemical Abstracts, 74:112368K (1971).
Bushma et al, the Chemical Abstracts, 92:105249r (1980).
Kypson et al, the Chemical Abstracts, 87:194780u (1977).
Aussedat, "Cardiovasc. Res." 17:145-151 (1983).
Aussedat et al, "Mol. Physiol." 6:247-256 (1984).
Aussedat et al, "J. Physiol" 78:331-336 (1982).
Buckley et al "Circ. Res." 7:847-867 (1959).
Kuznetsova et al, "Farmakol.-Toksikol" 2:170-173 (1981).
Kypson et al, "J. Mol. Cell. Cardiol." 10:545-565 (1978).
Meerson et al, "Kardiologiva" 25:91-93 (1985).
Rossi et al, "European Heart Journal" 5:155-162 (1984).
Eliseev et al, "Khim-Farm. Zh." 19:694-696 (1985).
Williams et al, "Aust. N.Z. J. Med." 6:Supp. 2, 60-71 (1976).
Swain et al, "P.N.A.S. (USA)" 79:655-659 (1982).
Kypson et al, "Biochem. Pharmacol." 26:1585-1591 (1977).
Pastoris et al, "Pharm. Ed. Sci." 40:442-453 (1985).
Kypson et al, "J. Pharm. Exp. Ther." 199:565-574 (1976).
Gasser et al, "Science" 213:777-778 (1981).
Klubes et al, "Cancer Chemother. Pharmacol." 17:236-240 (1986).
Bucher et al, "Biochem. Phys. Acta" 174:491-502 (1969).
Bushma et al, "Bull. Exp. Biol. Med." 88:1480-1483 (1980).
Chernukh et al, "Bull. Exp. Biol. Med." 70:1112-1114 (1970).
Diamondstone et al, "Biochim. Biophys. Acta" 57:583-587 (1962).
Elrick et al, "Metabolism" 11:46-55 (1962).
Yamada et al, "J. Biol. Chem." 243:1649-1655 (1968).
Shah et al, "J. Anim. Morphol. Physiol." 25:193-200 (1978).
Shah et al, "J. Anim. Morphol. Physiol." 21:132-139 (1974).
Songu et al, "Metabolism" 30:119-122 (1981).
Garmanyuk et al, "Farmakol. Toksikol." 50-52 (1979).
Trovarelli et al, "Neurochemical Research" 9:73-79 (1984).
Dwivedi et al, "Toxicol. Appl. Pharmacol." 31:452 (1978).
Geiger et al, "J. Neurochem." 1:93 (1956).
Sepe, "Minerva Medica" 61:5934 (1970).
Jann et al, "Minerva Medica" 60:2092 (1969).
Beranek et al, "Collection Czechslovak Chem. Commun." 42:366-369 (1977).
Sasaki et al, "Chem. Pharm. Bull" 15:894-896 (1967).
Samoileva et al, "Bull. Acad. Sci. USSR Div. Chem. Sci", 30:1306-1310 (1981).
Watanabe et al, "Angew. Chem.", 78:589 (1986).
Reese et al, "Tetrahedron Letters" 29:2459-2465 (1965).
Lortet et al, The Chemical Abstracts, 105:112608y (1986).
Lortet et al, Basic Res. Cardiol. 81:303-310 (1988).
Lim et al, Antimicrobiol Agents and Chemotherapy, 31:998-1001, 1987.
Rosowsky et al, Cancer Treatment Reports 85(1-2): 93-99, 1981.
Bamat Michael K.
von Borstel Reld W.
Kunz Gary L.
Pro-Neuron, Inc.
Robinson Douglas W.
LandOfFree
Method of delivering exogenous uridine or cytidine using acylate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of delivering exogenous uridine or cytidine using acylate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of delivering exogenous uridine or cytidine using acylate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2013744